References
- Ashburn, T.T. & Thor, K.B. (2004) Drug repositioning: identifying and developing new uses for existing drug. Nature Reviews Drug Discovery 3, pp 673-683.
- Campillos, M., Kuhn, M., Gavin, A.C., Jensen, L.J., & Bork, P. (2008) Drug target identification using side-effect similarity. Science 321, pp 263-266.
- Chiang, A.P. & Butte, A.J. (2009) Systematic evaluation of drug-disease relationships to identify leads for novel drug uses. Clinical Pharmacology & Therapeutics 86, pp 507-510.
- Dudley, J.T., Deshpande T., & Butte, A.J. (2011) Exploiting drug-disease relationships for computational drug repositioning. Briefings in Bioinformatics 12, pp 303-311.
- Gottlieb, A., Stein, G.Y., Ruppin, E., & Sharan, R. (2011) PREDICT: a method for inferring novel drug indications with application to personalized medicine. Molecular Systems Biology 7, p 496.
- Hu, G. & Agarwal P. (2009) Human disease-drug network based on genomic expression profiles. PLoS One 4, p e6536.
- Hurle, M.R., Yang, L., Xie, Q., Rajpal, D.K., Sanseau, P., & Agarwal P. (2013) Computational drug repositioning: from data to therapeutics. Clinical Pharmacology & Therapeutics 93, pp 335-341.
- Iorio, F., Bosotti, R., Scacheri, E., Belcastro, V., Mithbaokar, P., Ferriero, R. et al. (2010) Discovery of drug mode of action and drug repositioning from transcriptional responses. Proceedings of the National Academy of Sciences of the United States of America 107, pp 14621-14626.
- Jeh, G. & Widom, J. (2002) SimRank: a measure of structural-context similarity, Proceedings of the 8th International Conference on Knowledge Discovery and Data Mining (ACM SIGKDD), pp 538-543.
- Keshava Prasad, T.S., Goel, R., Kandasamy, K., Keerthikumar, S., Kumar, S. Mathivanan, S. et al. (2009) Human Protein Reference Database--2009 update. Nucleic Acids Research 37, pp D767-772.
- Lamb, J., Crawford, E.D., Peck, D., Modell, J.W., Blat, I.C., Wrobel, M.J. et al. (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, pp 1929-1935.
- Li, J. & Lu, Z. (2012) A New Method for Computational Drug Repositioning Using Drug Pairwise Similarity, Proceedings of the IEEE International Conference on Bioinformatics and Biomedicine (BIBM).
- Li, J. & Lu, Z. (2013) Pathway-based Drug Repositioning Using Causal Inference. BMC Bioinformatics. 2013. 14(Suppl 16):S3 doi:10.1186/1471-2105-14-S16-S3.
- Li, J., Zhu, X., & Chen J.Y. (2009) Building disease-specific drug-protein connectivity maps from molecular interaction networks and PubMed abstracts. PLoS Computational Biology 5, p e1000450.
- Li, Q., Cheng T., Wang Y., & Bryant, S.H. (2010) PubChem as a public resource for drug discovery. Drug Discovery Today 15, pp 1052-1057.
- Lu, Z., Agarwal, P., & Butte, A.J. (2013) Computational drug repositioning. Pacific Symposium on Biocomputing, pp 1-4.
- Magrane, M. & Consortium, U. (2011) UniProt Knowledgebase: a hub of integrated protein data. Database (Oxford) 11, p bar009.
- Max, M.B., Lynch, S.A., Muir, J., Shoaf, S.E., Smoller, B., & Dubner, R. (1992) Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine 326, pp 1250-1256.
- Mowla, A., Mosavinasab, M., Haghshenas, H., & Borhani Haghighi, A. (2007) Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo -controlled clinical trial. Journal of Clinical Psychopharmacology 27, pp 484-487.
- Saules, K.K., Schuh, L.M., Arfken, C.L., Reed, K., Kilbey, M.M., & Schuster, C.R. (2004) Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive- behavioral group therapy. American Journal on Addictions 13, pp 438-446.
- Scannell, J.W., Blanckley, A., Boldon, H., & Warrington, B. (2012) Diagnosing the decline in pharmaceutical R&D efficiency. Nature Reviews Drug Discovery 11, pp 191-200.
- Shaughnessy, A.F. (2011) Old drugs, new tricks. British Journal of Medicine 342, p d741.
- The U.S. FDA (2013) Orange Book: Approved drug products with therapeutic equivalence evaluations, 33rd Edition. Retrieved from the World Wide Web November 5, 2014: http://www.accessdata.fda.gov/scripts/cder/ob/
- Wang, Y., Xiao, J., Suzek, T.O., Zhang, J., Wang, J., & Bryant, S.H. (2009) PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Research 37, pp W623-633.
- Wishart, D.S., Knox, C., Guo, A.C., Cheng, D., Shrivastava, S., Tzur, D. et al. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Research 36, pp D901-906.